Pregnancy associated breast cancer: a case report.
Despite its infrequency, pregnancy associated breast cancer implies multiple therapeutic dilemmas. Our patient, a 32-year-old Caucasian, gravida 2, para 2, was diagnosed with cancer of the left breast in the 19th week of gestation. Shortly after she underwent quadrantectomy plus axillary lymph node dissection. Chemotherapy was initiated in the 22(+6) week--four cycles of a combination of endoxan, farmorubicin, and fluorouracil. The patient gave birth in the 35(+6) week to a healthy baby with no apparent malformations. During puerperium she received two more cycles of chemotherapy. She is currently undergoing radiotherapy with tangential fields. Although it is too early to draw conclusions, the malignancy seems to be inactive.
Ginopoulos
P V
PV
Department of Medical Oncology, Agios Andreas Hospital, Greece.
Michail
G D
GD
Kourounis
G S
GS
D000328:Adult; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D001943:Breast Neoplasms / Q000175:diagnosis* / Q000188:drug therapy / Q000473:pathology / Q000601:surgery; D003131:Combined Modality Therapy; D003520:Cyclophosphamide / Q000008:administration & dosage; D003937:Diagnosis, Differential; D015251:Epirubicin / Q000008:administration & dosage; D005260:Female; D005472:Fluorouracil / Q000008:administration & dosage; D006801:Humans; D007231:Infant, Newborn; D008197:Lymph Node Excision; D015412:Mastectomy, Segmental; D011247:Pregnancy; D011252:Pregnancy Complications, Neoplastic / Q000175:diagnosis* / Q000473:pathology / Q000601:surgery; D011262:Pregnancy Trimester, Second
D015251:Epirubicin; D003520:Cyclophosphamide; D005472:Fluorouracil